Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.

Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Feb 2004

Zoli Wainer, Ricotti Luca, Tesei Anna, Ulivi Paola, Gasperi Campani Anna, Fabbri Francesco, Gunelli Roberta, Frassineti Giovanni Luca, Amadori Dino

Abstract excerpt

PURPOSE: The aim of the study was to evaluate the activity of epidoxorubicin (EPI) and gemcitabine (GEM) and to define the most effective schedule in human bladder cancer cells. EXPERIMENTAL DESIGN: The study was performed on HT1376 and MCR cell lines. Cells were exposed for 1 and 24 h to drugs u...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotics, Antineoplastic
Share to Comet Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Deoxycytidine

Share to Drug Synergism

Share to Epirubicin

Share to Gemcitabine

Share to Inhibitory Concentration 50

Share to Rhodamines

Source

Identifiers

PMID: 14977854
DOI: 10.1158/1078-0432.ccr-1107-03

Genes

GEM
BAX

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-14977854-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.PMID 14977854Read ↗

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell linesSemantic proximity Read ↗

In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell linesSemantic proximity Read ↗

A co-formulation of Interferons alpha2b and gamma distinctively targets Cell Cycle in the glioblastoma-derived cell line U-87MGSemantic proximity Read ↗

Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells.Semantic proximity Read ↗

Gemcitabine/Cisplatin Treatment Induces Concomitant SERTAD1, CDKN2B and GADD45A Modulation and Cellular Changes in Bladder Cancer Cells Regardless of the Site of TP53 Mutation.Semantic proximity Read ↗

Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: The importance of schedulingSemantic proximity Read ↗

Defining the mode of action of cisplatin combined with a phosphoramidate modification of gemcitabineSemantic proximity Read ↗

Dichloroacetate and PX-478 Exhibit Strong Synergistic Effects in a Various Number of Cancer Cell Lines.Semantic proximity Read ↗

Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cellsSemantic proximity Read ↗

Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell linesSemantic proximity Read ↗

Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.Semantic proximity Read ↗

Supraadditive effect of 2 ′ ,2 ′ -difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell linesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.